Ovidrel Or Ovitrelle Market Report 2026

Ovidrel Or Ovitrelle Market Overview

• The Ovidrel Or Ovitrelle market growth in the historic period has been driven by increasing infertility prevalence, wider acceptance of fertility treatments • Market expansion is supported by growing demand for ART procedures, rising maternal age globally • Growth Driver: Rising Infertility Rates Fuel Growth Of The Market • North America was the largest region in 2025.

What Is Covered Under Ovidrel Or Ovitrelle Market?

Ovidrel, also known as Ovitrelle, is a prescription medication containing choriogonadotropin alfa, a synthetic form of the hormone human chorionic gonadotropin (hCG). It is used in fertility treatments to trigger ovulation or support the luteal phase in women undergoing assisted reproductive technologies. Ovidrel helps mature eggs after ovarian stimulation and can also induce ovulation in women with conditions like polycystic ovary syndrome (PCOS). The main types of ovidrel or ovitrelle formulations are pre-filled syringes and vials. Pre-filled syringes offer ready-to-use, single-dose medication for home injections, ensuring accurate dosing and minimizing contamination risk in fertility treatments. It is applicable in various indications, such as assisted reproductive technology (ART) and ovulation induction, and it is distributed through several distribution channels, including hospitals and clinics, retail pharmacies, and online pharmacies.

What Is The Ovidrel Or Ovitrelle Market Growth Forecast?

The growth in the forecast period can be attributed to growing demand for ART procedures, rising maternal age globally, increasing investments in fertility healthcare infrastructure, broader insurance coverage for fertility treatments, expansion of home-administered fertility therapies. Major trends in the forecast period include increasing use of assisted reproductive technologies, rising adoption of pre-filled fertility injections, growing demand for ovulation induction therapies, expansion of fertility treatment accessibility, enhanced focus on patient-friendly drug delivery.

Global Ovidrel Or Ovitrelle Market Segmentation

1) By Formulation: Pre-Filled Syringes, Vials 2) By Indication: Assisted Reproductive Technology (ART), Ovulation Induction 3) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies

What Are The Drivers Of The Ovidrel Or Ovitrelle Market?

The rising infertility rates are expected to propel the growth of the ovidrel or ovitrelle market going forward. Infertility rates refer to the proportion of individuals or couples unable to conceive after a year of regular, unprotected intercourse. Infertility rates are driven by delayed childbearing, lifestyle factors like obesity and stress, and environmental influences. Ovidrel or Ovitrelle enhances infertility treatment by inducing ovulation with recombinant human chorionic gonadotropin (hCG), facilitating egg release for successful conception. For instance, in August 2025, according to the Canadian Fertility and Andrology Society, a UK-based national professional organization advancing reproductive medicine and science, in Canada, around 8% of couples with female partners aged 15 to 45 are affected by infertility. Therefore, rising infertility rates are driving the growth of the ovidrel or ovitrelle industry. The increasing prevalence of polycystic ovary syndrome (PCOS) is set to propel the growth of the ovidrel or ovitrelle market moving forward. Polycystic ovary syndrome (PCOS) is a hormonal condition that leads to irregular menstrual cycles, ovarian cysts, and elevated androgen levels and is commonly associated with infertility and metabolic complications. Rising obesity rates, lifestyle changes, and better awareness and diagnosis of the condition drive the prevalence of PCOS. Ovidrel or Ovitrelle aids women with PCOS by stimulating ovulation, triggering the release of mature eggs, and enhancing conception chances during fertility treatments. For instance, in June 2023, according to reports published by the World Health Organization (WHO), a Switzerland-based government agency, polycystic ovary syndrome (PCOS) affects approximately 8-13% of women of reproductive age, with up to 70% of cases remaining undiagnosed. Therefore, the increasing prevalence of polycystic ovary syndrome (PCOS) is driving the growth of the ovidrel or ovitrelle industry. The rising healthcare expenditure is significantly driving the growth of the ovidrel or ovitrelle market in the future. Healthcare expenditure is the overall spending on medical services, treatments, and products within a healthcare system. Healthcare expenditure is driven by factors like aging populations, increased prevalence of chronic and infectious diseases, advancements in medical technology, and higher demand for quality healthcare services. Healthcare expenditure is expanding access to fertility treatments and advancing therapies, enabling more women, especially those with PCOS, to afford medications like Ovidrel or Ovitrelle. This support helps stimulate ovulation and improve fertility outcomes. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government department, total healthcare expenditure increased by 5.6% in nominal terms between 2022 and 2023, compared with growth of 0.9% in 2022. Therefore, rising healthcare expenditure is driving the growth of the ovidrel or ovitrelle industry.

Key Players In The Global Ovidrel Or Ovitrelle Market

Major companies operating in the ovidrel or ovitrelle market are Merck KGaA, Eli Lilly and Company

Regional Insights

North America was the largest region in the ovidrel or ovitrelle market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Ovidrel Or Ovitrelle Market?

The ovidrel or ovitrelle market consists of sales of cartridges, auto-injectors, and pen devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ovidrel Or Ovitrelle Market Report 2026?

The ovidrel or ovitrelle market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ovidrel or ovitrelle industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.